A

    Annexon Inc (ANNX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.94
    -0.03 (-0.60%)

    Market Cap: $942.21M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(13/26)
    Avg Surprise
    -208.08%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.26
    Range$-0.30 - $-0.21
    6 analysts
    EPS Revisions
    4
    0
    7d
    4
    0
    30d
    EPS Estimate Drift
    90d ago$-0.25+2.1%
    60d ago$-0.25+1.3%
    30d ago$-0.25+1.3%
    7d ago$-0.25+2.0%
    Current$-0.26
    Revenue Consensus
    $0
    Range$0 - $0
    10 analysts
    Dec 31, 2026
    EPS Consensus$-0.25
    Range$-0.35 - $-0.19
    5 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.25---
    Sep 26EST
    		-$-0.26---
    Jun 26
    		$-0.28$-0.23-21.74%Miss+17.6%
    Mar 26
    		$-0.23$-0.30+23.33%Beat+37.8%
    Dec 25
    		$-0.28$-0.32+12.47%Beat+15.2%
    Sep 25
    		$-0.37$-0.34-8.82%Miss-48.0%
    Jun 25
    		$-0.34$-0.36+5.56%Beat-47.8%
    Mar 25
    		$-0.37$-0.29-27.59%Miss-76.2%
    Dec 24
    		$-0.33$-0.29-12.51%Miss+8.3%
    Sep 24
    		$-0.25$-0.27+7.41%Beat+41.9%
    Jun 24
    		$-0.23$-0.24+4.17%Beat+51.1%
    Mar 24
    		$-0.21$-0.35+40.00%Beat+59.6%
    Dec 23
    		$-0.36$-0.44+18.18%Beat+25.0%
    Sep 23
    		$-0.43$-0.51+15.69%Beat+15.7%
    Jun 23
    		$-0.47$-0.54+12.96%Beat+51.0%
    Mar 23
    		$-0.52$-0.52+0.00%Beat+43.5%
    Dec 22
    		$-0.48$-0.53+9.43%Beat+50.5%
    Sep 22
    		$-0.51$-0.92+44.57%Beat+45.2%
    Jun 22
    		$-0.96$-0.95-1.05%Miss-17.1%
    Mar 22
    		$-0.92$-1.03+10.68%Beat-35.3%
    Dec 21
    		$-0.97$-0.92-5.43%Miss-59.0%
    Sep 21
    		$-0.93$-0.88-5.68%Miss-60.3%
    Jun 21
    		$-0.82$-0.68-20.59%Miss+97.2%
    Mar 21
    		$-0.68$-0.65-4.62%Miss+79.4%
    Dec 20
    		$-0.61$-0.44-38.64%Miss-916.7%
    Sep 20
    		$-0.58$-0.35-65.71%Miss-1060.0%
    Jun 20
    		$-28.87$-0.53-5347.17%Miss-
    Mar 20
    		$-3.30$-2.13-54.93%Miss-
    Sep 19
    		$-0.06$0.00N/AMiss-
    Jun 19
    		$-0.05$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-4.26EV/EBITDA-2.47x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-105.30%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio5.53xQuick Ratio5.53x
    Trading Statistics
    Beta1.22Avg Volume2.53M
    52-Week High$7.1852-Week Low$2.03

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.14
    SMA 20$5.24
    SMA 50$5.40
    SMA 200$5.35
    EMA 10$5.11
    EMA 20$5.19
    EMA 50$5.30
    EMA 200$5.01

    MACD

    Line: -0.10Signal: -0.07Hist: -0.02

    ADX

    ADX: 12.2+DI: 17.9-DI: 24.5

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down8.0
    PSAR$5.51

    Bollinger Bands

    Upper Band$5.60
    Lower Band$4.88
    %B Position1364%(Upper)
    Band Width0.08

    RSI (14-Day)

    Neutral
    42.7

    Momentum Oscillators

    Stoch %K32.1
    Stoch %D34.8
    Williams %R-82.3
    ROC (10d)-3.7%
    Momentum-0.19
    CCI (20d)-151.3
    MFI (14d)39.6

    Volatility Measures

    ATR (14d)$0.31(6.2%)
    StdDev (20d)0.18
    Hist Vol48.4%(High)

    Volume Flow

    VWAP$4.94
    OBV20.2M
    AD Line-38.0M
    CMF (20d)0.093

    Volume Metrics

    Avg Vol (20d)2.5M
    Vol Ratio0.9x
    VWMA (20d)$5.25

    Pivot Points

    R3$5.39
    R2$5.30
    R1$5.13
    Pivot Point$5.04
    S1$4.88
    S2$4.78
    S3$4.62

    Advanced Oscillators

    TSI-8.74
    Ultimate Osc50.0
    KST-52.45

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$3.40M$0$0$0$4.87M$0
    Cost of Revenue$0$0$945,000$0$0$0N/A$0$0$0$834,000$0
    Gross Profit$0$0$-945,000$0$0$0$1.70M$0$0$0$4.03M$0
    Operating Expenses$57.23M$46.05M$50.26M$57.02M$51.73M$57.41M$52.48M$39.44M$33.58M$28.57M$30.01M$34.78M
    R&D$46.59M$35.79M$42.66M$49.70M$44.16M$48.18M$43.35M$30.11M$25.03M$20.96M$23.27M$27.89M
    SG&A$10.64M$10.27M$7.60M$7.32M$7.57M$9.23M$9.13M$9.34M$8.55M$7.61M$6.74M$6.89M
    Operating Income$-57,227,000$-46,053,000$-50,258,000$-57,018,000$-51,726,000$-57,405,000$-52,479,000$-39,442,000$-33,580,000$-28,572,000$-30,009,000$-34,781,000
    Interest Income$1.88M$1.91M$2.00M$2.10M$2.57M$3.05M$3.89M$4.62M$3.97M$3.40M$2.12M$2.30M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-55,348,000$-44,142,000$-48,256,000$-54,922,000$-49,156,000$-54,356,000$-48,590,000$-34,824,000$-29,610,000$-25,176,000$-27,891,000$-32,482,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-55,348,000$-44,142,000$-48,256,000$-54,922,000$-49,156,000$-54,356,000$-48,590,000$-34,824,000$-29,610,000$-25,176,000$-27,891,000$-32,482,000
    EBITDA$-56,946,000$-46,146,000$-50,139,000$-56,947,000$-52,442,000$-58,718,000$-54,964,000$-42,004,000$-34,838,000$-29,171,000$-29,731,000$-34,838,000
    EBIT$-57,227,000$-46,053,000$-50,258,000$-57,018,000$-51,726,000$-57,405,000$-52,479,000$-39,442,000$-33,580,000$-28,572,000$-30,009,000$-34,781,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ANNX

    News

    Annexon (ANNX) Institutional Ownership 2026

    This article details the institutional ownership of Annexon (ANNX) as of 2026, providing data on institutional buyers and sellers, total inflows and outflows, and a list of major shareholders with their respective holdings and market values. It highlights that 105 institutional buyers invested $315.19M in the last 12 months, while 30 institutional sellers divested $18.85M. Key shareholders include Palo Alto Investors LP, Redmile Group LLC, and BlackRock Inc.

    MarketBeat•8/20/26•
    Neutral

    Annexon, Inc. Stock 12‑Month Price Target Raised to $15.71, Implies 198% Upside

    Annexon, Inc.'s average stock price target has been increased to $15.71 from $15 by 7 analysts, with forecasts ranging from $7 to $27 per share. This new target suggests a potential upside of approximately 198% based on the recent closing price. The consensus rating for ANNX remains a "Buy" from 10 analysts.

    TradingView•8/19/26•
    Bullish

    Bank of America Corp DE Has $23.60 Million Stock Holdings in Annexon, Inc. $ANNX

    Bank of America Corp DE significantly increased its stake in Annexon, Inc. (NASDAQ:ANNX) during the first quarter, now holding 4,259,995 shares valued at $23.60 million. Other institutional investors have also adjusted their positions, and a company director recently acquired over 600,000 shares. Annexon, a clinical-stage biotechnology company focusing on neurodegenerative and neuroimmune diseases, has seen varied analyst ratings, with an average "Hold" rating and a target price of $15.33.

    MarketBeat•8/18/26•
    Neutral

    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

    Annexon, Inc. (Nasdaq: ANNX) announced inducement grants to three new non-executive employees under the 2022 Employment Inducement Award Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). These employees received options to purchase 287,500 shares of Annexon common stock at an exercise price of $5.29, vesting over four years. This initiative aims to attract and retain talent for the biopharmaceutical company focused on neuroinflammatory diseases.

    The Manila Times•8/18/26•
    Neutral

    At $5.29, Annexon grants new employees options vesting over four years

    Annexon (Nasdaq: ANNX) announced inducement grants of options to purchase 287,500 shares of common stock to three new non-executive employees. These options, granted at an exercise price of $5.29 per share, vest over four years, with 25% on the first anniversary and the remainder monthly. The grants were made under the 2022 Employment Inducement Award Plan, in accordance with Nasdaq Listing Rule 5635(c)(4).

    Stock Titan•8/17/26•
    Neutral

    Frequently Asked Questions About ANNX

    Does ANNX pay dividends?
    Annexon Inc (ANNX) does not currently pay a regular dividend.
    What is ANNX's market cap?
    Annexon Inc (ANNX) has a market capitalization of $942.21M with a current stock price of $4.94.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In